Adc Therapeutics SA
ADCT
Market Cap$274.72M
Close$
$-1.36
150.2% downside
Current Fair Value
150.2% downsideOvervalued by 150.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $274.72 Million |
|---|---|
| Enterprise Value | $430.31 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.62 |
| Beta | 1.96 |
| Outstanding Shares | 107,202,374 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.98 |
|---|---|
| PEG | 11.54 |
| Price to Sales | - |
| Price to Book Ratio | -0.9 |
| Enterprise Value to Revenue | 6.17 |
| Enterprise Value to EBIT | -3.8 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.81 |
| Debt to Equity | -1.47 |
Revenue Sources
No data
Insider Trades
ESG Score
No data